New Biomarkers of Inflammation Identified as Risk Factors for Neuropathy
08/24/2018 · DDZ Deutsches Diabetes-Zentrum
Although many patients suffer from polyneuropathy, relatively little is currently known about its development, which also limits the therapeutic options. It is known that inflammatory processes contribute to other diabetic complications such as heart attack or stroke. The aim of this new study was therefore the extensive analysis of biomarkers that characterize inflammatory processes as a risk factor for distal sensory polyneuropathy (DSPN). Both people with type 2 diabetes and people in the elderly general population were examined.
A molecular switch may serve as new target point for cancer and diabetes therapies
08/13/2018 · FMP Leibniz-Forschungsinstitut für Molekulare Pharmakologie
If certain signaling cascades are misregulated, diseases like cancer, obesity and diabetes may occur. A mechanism recently discovered by scientists at the Leibniz- Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin and at the University of Geneva has a crucial influence on such signaling cascades and may be an important key for the future development of therapies against these diseases. The results of the study have just been published in the prestigious scientific journal 'Molecular Cell'.
Alexander von Humboldt Research Fellow at FLI
08/13/2018 · FLI Leibniz Institute on Aging - Fritz Lipmann Institute
Ukrainian cell biologist Dr. Yuliya Kurlishchuk has received a research fellowship for postdocs from the Alexander von Humboldt Foundation. With this funding, she is now a guest at the Leibniz Institute on Aging – Fritz Lipmann Institute (FLI) in Jena for the next two years. She is going to investigate the regenerative capacity of cells in the research group “Transcriptional Control of Tissue Homeostasis” of Dr. Björn von Eyss.
Healthy Ageing - Forschung aus erster Hand
Bioactive compound improves memory
Better understanding cardiovascular diseases